Spain· ES:77789
CARMELOSA QUALIGEN 5 MG/ML COLIRIO EN SOLUCION EN ENVASES UNIDOSIS
A medicinal product containing carmelosa, registered in Spain by Neuraxpharm Spain S.L.U..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- carmelosa
- Manufacturer
- Neuraxpharm Spain S.L.U.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo69874930EUR 5.93
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carmelosa in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAaqEye Carmellose 0.5% eye dropsEssential-Healthcare Ltd
- United StatesDRMITSUI HYDROCOLLOID WOUNDYIYANGYUAN LIFE SCIENCES (HONG KONG) CO., LIMITED
- SwitzerlandCellufluid
- IrelandCelluvisc 0.5 % w/v eye drops solution, unit doseAbbVie Limited
- CzechiaCELLUFLUIDAbbVie s.r.o., Praha
- NetherlandsCellufluid 0,5%, oogdruppels, oplossing, unit dose ampul, 5 mg/mlAbbVie B.V.
- GermanyCelluviscAbbvie Deutschland Gmbh & Co. Kg
- FranceCELLUVISC 4 mg/0,4 ml, collyre en récipient unidoseABBVIE
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Czechia · Cellufluid
- Denmark · Celluvisc
- Finland · Celluvisc
- France · Celluvisc
- United Kingdom (Northern Ireland) · Celluvisc
- Greece · Refresh Plus
- Ireland · Celluvisc
- Italy · Celluvisc
- Netherlands · Cellufluid, Celluvisc
- Portugal · Celluvisc
- Sweden · Cellufluid, Celluvisc
- Slovakia · Cellufluid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd82d219-50b5-48f7-a120-2fb5dd25cd58 GET /v1/drugs/cd82d219-50b5-48f7-a120-2fb5dd25cd58?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Sin Receta",
"estado": "{\"aut\":1374771038000}",
"nregistro": "77789",
"substance": "carmelosa"
}See everything about carmelosa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.